Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Other Non-Current Liabilities (2020 - 2024)

Historic Other Non-Current Liabilities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $1.6 million.

  • Burning Rock Biotech's Other Non-Current Liabilities rose 11414.84% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 11414.84%. This contributed to the annual value of $1.4 million for FY2024, which is 12382.45% up from last year.
  • Burning Rock Biotech's Other Non-Current Liabilities amounted to $1.6 million in Q3 2025, which was up 11414.84% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Other Non-Current Liabilities registered a high of $8.6 million during Q4 2021, and its lowest value of $35000.0 during Q1 2021.
  • Over the past 5 years, Burning Rock Biotech's median Other Non-Current Liabilities value was $676000.0 (recorded in 2024), while the average stood at $1.7 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first surged by 2436571.43% in 2021, then plummeted by 9301.65% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Other Non-Current Liabilities stood at $8.6 million in 2021, then tumbled by 93.02% to $598000.0 in 2022, then rose by 6.69% to $638000.0 in 2023, then surged by 123.82% to $1.4 million in 2024, then rose by 9.17% to $1.6 million in 2025.
  • Its Other Non-Current Liabilities stands at $1.6 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.5 million for Q1 2025.